Read + Share
Kato T, Ono H, Fujii M, Akahoshi K, et al. Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is
involved in drug resistance of pancreatic cancer cells. PLoS One 2021;16:e0252917.
PMID: 34111175
|
 |
|
Kato T, Ono H, Fujii M, Akahoshi K, et al. Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is
involved in drug resistance of pancreatic cancer cells. PLoS One 2021;16:e0252917.
PMID: 34111175
|
|
|
|